Guardant Health

Attention is on a Guardant Health put option contract expiring in October 2026 with a $190 strike price, listed under ticker GH261016P00190000. The option's interactive stock chart is being tracked by investors following the cancer diagnostics company's stock. With a strike price far above typical trading levels, the long-dated contract is drawing interest as a possible bearish or hedging position.

Investors are tracking Guardant Health, Inc., the US precision oncology company traded under the ticker GH, as its stock price, quote and trading history draw renewed interest on financial platforms. No specific earnings announcement, regulatory decision or company statement has been confirmed in current coverage. The stock is being widely watched by traders following cancer diagnostics companies.